InvestorIdeas.com | big ideas for the small cap investor

search subscribe advertise submitnews

   research       membership       insiders corner       investor alerts       audio       marketplace       green investor       stock directories       trading center       JOBS     

Biotech and Pharmaceutical Industry Research: Biotech Stocks, Biotech News and Pharmaceutical Industry Research

Biotech Industry Stocks BiotechIndustryStocks.com is an investor and industry news portal for the Biotech and Pharmaceutical sector. The BIS website does not make recommendations, but offers news, exclusive articles and columnists, audio interviews, investor conferences, blogs, and a list of stocks in the sector.
Top Ranked Investor Site for
Biotech and Pharmaceutical Stock Research on Google.com, Yahoo.com and MSN Search
Services for investors and public & private companies: click here

Biotech and Pharmaceutical Industry Research Showcase - Learn more about these emerging companies and technologies in the biotech and pharmaceutical sector. (Biotech and Pharmaceutical Industry Research is compensated by these companies. Please read our disclaimer.)

Drug Delivery Industry Research

10 Best Performing Drug Delivery Stocks

Two analysts and top management from ten sector firms examine the Drug Delivery sector in this 46 - page Drug Delivery Issue from The Wall Street Transcript.

Center for Drug Delivery Research

List of Public Drug Delivery Stocks


Stock Maven List of Drug Delivery Stocks


Pharmcast List of Drug Delivery Stocks

Biotech Industry Research

Yahoo! Finance Biotech News

Yahoo! Finance

Top Companies by Market Cap

1. Pfizer Inc (NYSE: PFE)
2. Johnson & Johnson (NYSE: JNJ)
3. Merck & Co., Inc. (NYSE: MRK
4. GlaxoSmithKline plc (NYSE: GSK)
5. Novartis AG (NYSE: NVS)

Biotech Stocks Realize Impressive Gains 
April 26, 2004
OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) Stock Soars Up $52.96 in One Day Gain OSI Pharmaceuticals, Inc. (Nasdaq: OSIP - News), Genentech, Inc. (NYSE: DNA - News), and Roche (SWX Zurich) today announced that a Phase III study of Tarceva(TM) (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva(TM) living longer than those in the placebo arm of the study. The trial also met secondary endpoints including improving time to symptomatic deterioration, progression-free survival and response rate. OSI will work with the Food and Drug Administration (FDA) to complete the New Drug.

TWST BIOTECH STOCKS - Recent Analyst and CEO interviews

The latest headlines and interview extracts:

Analyst likes Cell Therapeutics (9/29/03)
- MATTHEW L. KAPLAN, Punk Ziegel & Company
- Drug Delivery

Analyst recommends AVI BioPharma (8/28/03)
- RENI BENJAMIN, PHD, Rodman and Renshaw
- Biotechnology

Analyst says Geron has cancer vaccine data coming up that could move the stock significantly (8/28/03)
- RENI BENJAMIN, PHD, Rodman and Renshaw
- Biotechnology

Financial Director sees partners international diversity as edge (8/26/03)
- HP WIESE, Global Life Sciences Ventures
- Biotechnology

Finance Director says Crucell's success lies in licensing for development (8/26/03)
- LEONARD KRUIMER, Crucell
- Biotechnology

Click here for more headlines and interview extracts

Drug Industry Links

Drug Delivery

Drug Delivery Technology


Drug Discovery


Drug InfoNet


Drug Discovery Online

Biotech Industry Links

Long Term Care Insurance Free Comparison Quotes and Research Center - Tips, tools, traps and tricks exposed for winning the insurance
game now. Trusted public service decision assistance thru Buyers Advocates sponsored by the National Advisory Council since 1995.
Long Term Care Insurance Rate Reporter - Insider Secrets - Long term care insurance strategies, companies & rates compared as a public service for buyers. Personal guidance sponsored by the National Advisory Council's Buyers Advocate Outreach.
NanoBiotech News
is the first and only newsletter providing weekly intelligence, insider information, up-to-the-minute news and analysis, and online delivery.
All Focused Squarely on the Emerging Nanobiotech Market!
Academic Info: Biotechnology
 - A directory of Internet resources for the study of biotechnology.
About Biotech
 - Discusses issues, careers, and other topics. From Genentech.
Bio.com
 - The editorial focus is on the technology of the life sciences.
Bio Drug Technology - Contains links to organizations, publications, career information and news about projects in the field.
BioExchange.com - Portal for biochemistry, cell biology, cloning, proteomics, biopharmaceuticals and related sciences. Features industry news, protocal information, careers, books, available software and an online market.
Bioscience Technology 
Biotech Browser - Database software (running on Windows) that includes listings of companies, clinical trials, products and services related to the field. Includes information about different features offered in the package. Requires a subscription fee.
Biotech Directory  
Biotech Find
 - Searchable database listings for companies, universities, and events. Includes featured articles, industry news and suggested book readings.
BioTech Professional Resources - Portal includes links to careers, research facility programs, organizations, regulations, events, and companies related to the field. Compiled by Indiana University.
Biotech Media - Contains glossary of terms. Includes database of products and services with corresponding print materials for purchase or subscription.
Biotech
Resource - Portal of companies, tutorials, and information sites. From the University of New Mexico.
Biotechnology Research Tools - Database of pages covering various topics in the field. Selected by bioscientists.
Biotechnology Resources on the Internet 
Searchable database of government regulatory pages, biomedical, bioinformatics, chemical engineering and other related links.

Biotechnology Information Resource
 
Includes links to webpages and publications that focus on genetically modified crops and animals, as well as environmental safety.
Biotech Insight - A stock letter for biotechnology investors.
Biotech Ontario - Resource for biotechnology information, including companies, biomedical and genomic research, incubation, venture capital and technology transfer.

Biotech News
 - News breakthroughs & innovations.
BiotechWatch.com
 - Information on publicly trade companies.
Bio Supply Net - Searchable database of biotechnology products and companies that supply them. Includes contact information.
Biotech Support Services
- Information about companies, research institutes, educational facilities, journals, suppliers, software, literature, resources, and government facilities.
BioWorld
- Online  News & Information Source
BioCentury
 - Business intelligence.
Biospace.com - An aggregation of news, information, and services for those who work and invest in the biotechnology and pharmaceutical industries.
Biotaq.com - News & new products.
The Bull Market Biotech Investor  
Is a FREE publication that focuses on the changing Biotech and Pharmaceutical world we live in and the companies that are going to profit from these changes. 
Hardin MD - Selected lists of internet sources in biotechnology, molecular, biology, genetics. From the University of Iowa.
Med Web Plus - Biotechnology - Searchable database of genetics, microbiology, companies, associations and resource links.
Nature Biotechnology
 - Presents scientific advances in life sciences. Includes a list of companies and an archive of published articles. Subscription required for full access.
Southwest Biotechnology and Informatics Center - Established to provide a single access point to resources for agricultural, pharmaceutical, and related fields.
Bio Track - Focuses on information related to the regulatory oversight of biotechnology derived products.

Bio Wisdom - Database of research and development news in the biopharmaceutical field. Must sign up to use.




 

Biotech and Pharmaceutical Articles and News  

POZEN Hits All Primary Endpoints in Second Phase III Pivotal Trial for Trexima; NDA Submission Scheduled for 3Q 2005 dated April 21, 2005

Commonwealth Biotech gets contracts totaling $3M (CBTE) dated April 20, 2005

Pfizer Takes Painkiller Bextra Off Market

Genzyme Acquires Verigen AG, Bolstering Global Orthopaedic Franchise dated February 8, 2005

Merck Updates Status of VIOXX Litigation and SEC Inquiry dated Jan. 28, 2005

More News and Articles

Biotech and Pharmaceutical Industry News

2003 Is Biotech's Second Best Year Ever and 2004 Looks Even Better dated Dec 18,2003

Why Own Drug Delivery Stocks?

Burrill Life Sciences Indices

Life Sciences World

Medical Technology Stock Letter - Premier source for investment research in biotechnology growth stocks.

The Wall Street Transcript - Latest Headlines and Interviews on Biotech.

The Bull Market Biotech Investor is a FREE publication that focuses on the changing Biotech and Pharmaceutical world we live in and the companies that are going to profit from these changes.
The newsletter is written by Dr. Robert Mendoza, who has performed over a decade of research studies encompassing the fields of gene therapy, virology, immunology and molecular biology.

Click here for the free newsletter

Biotech Research and Investment Links

Biotechnology 101
Advice on researching and investing in biotech companies from Biotech Navigator
Biospace Movers Page
Keep track of the most actives, losers, and gainers in Biotech/Biomedicine. Links include mutual funds, clinical trial news, and regional hotbeds.
biotech.equityresearchcenter.com/
Clinical trial listing service
Facts Online
Investment, merger, acquisition, and income information on private and public technology-based companies.
International biotechnology resources
InvestBio - Biotech Investing Tactics and Research
Take advantage of the most powerful investment sector, biotechnology. Receive unbiased investment information, research, news, and reports on which stocks to buy or sell in the biotechnology sector.
IPOs Inflate Stock Prices
Article showing how spinning off Genentech instantly raised its value from $11 billion to $16 billion.
links/index.php?ParentID=283 
NASDAQ Biotechnology 100 Index
List of companies with homepage and stock quote links.
Recombinant Capital's biotech strategic alliance database

Biotech Industry

Cracking the genetic code that defines the human organism promised to revolutionize the biotechnology industry -- but did it? A few years after Celera Genomics and the multinational, publicly funded Human Genome Project announced they'd completed their genomic maps, researchers have gained a deeper understanding of the root causes of some diseases - and opened many a can of worms.

The biggest can of worm is proteomics, the study of proteins. Genes merely contain the recipe for proteins, which interact to do the real work. Figuring out which genes encode which proteins and how the various proteins relate is the next big step in biotech. That step is pretty big: The approximately 30,000 genes in the human genome can encode anywhere from one to as many as a dozen proteins, some of which can be linked to diseases. The task of mapping the sequences of amino acids that make up all these proteins is daunting, but some firms are crazy enough to try. Large Scale Biology, Compugen, and Syrrx are among the companies heading up the proteomics charge.
For the full article, click here


TOP

Biotech Info
Free Investor & Industry Newsletter

Our Current List Biotech / Pharma Stocks

Recent Portal News for Biotech and Pharmaceutical Industry Research


HIV/AIDS Industry Report April 2005

Biotechnology News - PR Web.com

Exclusive Biotech Stock Articles:

HomelandDefenseStocks.com Reports on The Security Implications of AIDS 

AstraZeneca Announces IRESSA Drug Fails Lung Cancer Trial dated 17th, 2004


Pfizer Inc. Releases Statement Regarding Cardiovascular Risks of Drug Celebrex datedDecember 17th, 2004
   

Biotech Stock News
Immunogen pops on Genetech deal dated May 3, 2005

CuraGen's net loss rises to 39 cents a share dated April 28, 2005

ImmunoGen Shares Gain Due To Second Genentech Licensing Deal dated April 28, 2005

Martek Biosciences Shares Fall Upon Reaffirmation of Second Quarter Revenue Forecast dated April 28th, 2005

Biogen earnings hurt by Tysabri dated April 28, 2005

More Biotech Stock News
 
More Investor Information and Tools 
Additional Industry Research Portals for Investors and Industry

Homeland Security Portals
BiodefenseStocks.com

BorderAndPortSecurity.com

HomelandDefenseStocks.com

NonlethalStocks.com

Energy Portals
CoalSectorStocks.com

EnergyStockNews.com

NaturalGasStocks.com

OilandGasStockNews.com

Clean Tech Portals
EnvironmentStocks.com

FuelCellCarNews.com

GreenTechInvestor.com

HydrogenFuellingStation.com

RenewableEnergyStocks.com

Resources Portals
Gold-MiningStocks.com

MiningSectorStocks.com

Water-Stocks.com

Science & Technology Portals
BiotechIndustryStocks.com

NanotechnologyInvestment.com

RFIDInvesting.com

Internet & Technology Portals
DigitalMediaStocks.com

GamingIndustryStocks.com

InternetSearchEngineStocks.com

InvestingInWireless.com

OnlineGamingStocks.com

OnlineInvestorConference.com

TechSectorStocks.com

TelecomIndustryStocks.com

International Markets Portals
China-AsiaStocks.com

IndiaStockMarket.com

Global Investor Markets

Consumer / Retail Markets Portals
BeverageStocks.com

HomebuilderStocks.com

FireSafetyResearch.com

LowCarbInvesting.com

MusicIndustryStocks.com

ToyIndustryStocks.com

Additional Affiliated Homeland Security Portal
NationalHomelandSecurity
Knowledgebase.com
 
Disclaimer

Disclaimer

Additional Disclaimer

ECON Corporate Services, Inc.

© 2000 - 2008 InvestorIdeas.com®, ECON

about us | partners / links | company showcase | contact | employment | disclaimer | privacy policy | sitemap